Management of Diabetes Mellitus Patients With Retinopathy

Completed

• Conditions: Retinopathy; Diabetes Mellitus

• Registration Number: NCT00828425
• Lead Sponsor: AstraZeneca

Brief Summary

Aim of this NIS is to retrospectively document the management of diabetic patients with retinopathy in a naturalistic setting in Switzerland. Following elements are going to be analyzed:

* which medication are used to keep blood pressure under control?

* which medication are used for metabolic control?

* the average control level of metabolism and blood pressure is compliant with the international guidelines?

* laser photocoagulation plays a role in the control of metabolism and blood pressure?

* there are differences in the control of metabolism and blood pressure between patients with DM I or DM II?

* there is an influence of renal failure on the choose of medication?

Detailed Description

Not available

Study Timeline

• Study Start: 2008-12
• Study First Submitted: 2009-01-23
• Study First Submitted QC: 2009-01-23
• Study First Posted: 2009-01-26
• Study Completion: 2009-08
• Status Verified: 2010-08
• Last Update Submitted: 2010-08-17
• Last Update Posted: 2010-08-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2500

Inclusion Criteria

• Diabetic patients
• Diabetic retinopathy

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood lipids, glycemia, HbA1C, blood creatinine, proteinuria, body weight	every 3 months
evolution of diabetic retinopathy	every 3 months

Secondary Outcome Measures

Name	Time	Method
concomitant medication	every 3 months

Trial Locations

Locations (1)

Research Site; 🇨🇭 Winterthur, ZH, Switzerland